$ESRX Headlines CVS, Cardinal Health in generics sourcing

New Post Public Reply Private Reply Replies (0) Message Board

Dec 12, 2013 at 9:59 AM

$ESRX Headlines

CVS, Cardinal Health in generics sourcing venture 12:42 p.m. Dec. 10, 2013 - MarketWatch.com
Cardinal Health profit up 25%, but sales fall 6:53 a.m. Oct. 31, 2013 - MarketWatch.com
Zynga rallies; Amazon hits all-time high 3:31 p.m. Oct. 25, 2013 - Sue Chang
Microsoft, Amazon shares surge on earnings 5:32 p.m. Oct. 24, 2013 - Wallace Witkowski
Express Scripts profit up 9% on lower costs 4:47 p.m. Oct. 24, 2013 - MarketWatch.com
Ford, Microsoft, Amazon are stocks to watch 4:00 a.m. Oct. 24, 2013 - Sue Chang
The market in a minute: Playing with volatility 7:42 a.m. Oct. 21, 2013 - The Trading Deck
Arena shares surge as marketer doubles sales force for diet drug 11:41 a.m. Oct. 15, 2013 - Russ Britt
BlackBerry slides on report of massive layoff 3:41 p.m. Sept. 18, 2013 - Sue Chang
Walgreen hits new high after Goldman calls it 'underappreciated' 10:37 a.m. Sept. 12, 2013 - Russ Britt
S&P 500 breaks from major resistance 11:38 a.m. Sept. 11, 2013 - Michael Ashbaugh
Apple tops $500 ahead of iPhone update 3:18 p.m. Sept. 9, 2013 - Sue Chang
With new partnership deal in place, Walgreen soundly beats sales views 11:53 a.m. Sept. 5, 2013 - Russ Britt
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey
CVS Caremark net up 16%, helped by generics 6:32 a.m. Aug. 6, 2013 - MarketWatch.com
Express Scripts, Vertex provide highlights on earnings Tuesday 2:06 p.m. July 30, 2013 - Russ Britt
Herbalife shares rally on earnings, outlook 5:42 p.m. July 29, 2013 - Wallace Witkowski
Express Scripts loses CFO, beats forecasts, boosts full-year outlook 4:40 p.m. July 29, 2013 - Russ Britt
Express Scripts profit surges; CFO to step down 3:36 p.m. July 29, 2013 - MarketWatch.com
The market in a minute: Time to collar the S&P 8:28 a.m. July 29, 2013 - The Trading Deck

Deutsche downplays alleged "price war" for Gilead, AbbVie HCV drugs 2:47 p.m. Dec. 11, 2013 - Seeking Alpha
Gilead HCV Drug May Face Price War; Rival AbbVie Up 2:08 p.m. Dec. 10, 2013 - Investors Business Daily
Gilead Hep C Drug Launch Threatened by Price Concerns 1:56 p.m. Dec. 10, 2013 - TheStreet.com
New Lifetime High Reached: Express Scripts (ESRX) 9:47 a.m. Dec. 10, 2013 - TheStreet.com
Express Scripts Enters $1.5 Billion Buyback Plan with Bank of America 9:10 a.m. Dec. 10, 2013 - WSJ.com
Growing Generic Drug Sales Offers Hope Of Higher Margins For Walgreen 1:41 p.m. Dec. 5, 2013 - Seeking Alpha
Promising November Sales for Walgreens - Analyst Blog 1:10 p.m. Dec. 5, 2013 - Zacks.com
CVS Caremark: Enhancing Its Revenue Streams 12:37 p.m. Dec. 5, 2013 - Seeking Alpha
RT Oncology Services Joins Express Scripts Pharmacy Network 7:05 a.m. Dec. 5, 2013 - benzinga.com
Warrior Capital's Major Sells in Review - VistaPrint, Google, Fiserv, Express Scripts 9:45 a.m. Nov. 30, 2013 - GuruFocus.com
Insider Trading Alert - VFC, ESRX, WLK, AFOP And MMS Traded By Insiders 10:15 a.m. Nov. 29, 2013 - TheStreet.com
CVS Caremark Static at Neutral - Analyst Blog 1:53 p.m. Nov. 27, 2013 - Zacks.com
Can CVS Caremark Continue This Bullish Run? 5:56 p.m. Nov. 26, 2013 - Wall St. Cheat Sheet
5 Stocks Raising The Health Services Industry Higher 12:04 p.m. Nov. 26, 2013 - TheStreet.com
Walgreen Takes Some Steps In New Direction 3:37 p.m. Nov. 25, 2013 - Investors Business Daily
Insider Trading Alert - CIEN, ACIW, ESRX, THG And EPL Traded By Insiders 10:03 a.m. Nov. 22, 2013 - TheStreet.com
UPDATE: Deutsche Bank Initiates Coverage on Express Scripts Holding as There are Still More Questions Than Answers 7:51 a.m. Nov. 21, 2013 - benzinga.com
Has Walgreen Hit a Wall? 10:42 a.m. Nov. 20, 2013 - Barrons.com
The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years 11:03 a.m. Nov. 19, 2013 - 247WallSt.com
The Affordable Care Act Will Drive Retail Pharmacies To Higher Profits 6:23 p.m. Nov. 14, 2013 - Seeking Alpha

Express Scripts Announces Accelerated Share Repurchase Transaction 8:32 a.m. Dec. 10, 2013 - PR Newswire
Market Coverage and Analysis: Express Scripts Holding, Cigna Corp., Health Net, and Molina Healthcare 10:23 a.m. Dec. 6, 2013 - PR Newswire
RainTree Oncology Services Joins Express Scripts Pharmacy Network 8:00 a.m. Dec. 5, 2013 - PR Newswire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
Official Statement, Stock Price Movements, and Public Offering of Common Stock - Research Report on Amgen, Biogen Idec, Express Scripts, Endo, and CSI 8:00 a.m. Nov. 26, 2013 - PR Newswire
FDA Approvals, Stock Price Movements, Published Studies, and Philanthropic Initiatives - Research Report on Johnson & Johnson, Express Scripts, Endo, Biogen and Covidien 8:00 a.m. Nov. 18, 2013 - PR Newswire
Critical Alerts For Aceto, Anadarko Petroleum, Express Scripts, Shire, and MetLife Released By InvestorsObserver 9:31 a.m. Nov. 12, 2013 - PR Newswire
Technical Study: Express Scripts Holding Co., Cigna Corp., Health Net Inc., and Molina Healthcare Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte 8:00 a.m. Nov. 8, 2013 - PR Newswire
Express Scripts to Present at the Credit Suisse Healthcare Conference 8:38 a.m. Nov. 4, 2013 - PR Newswire
Quarterly Results, Product Launches, and Trial Results - Research Report on Express Scripts, Baxter, IDEXX Laboratories, KYTHERA, and Spectranetics 4:11 p.m. Oct. 30, 2013 - PR Newswire
Express Scripts Launches Workers' Compensation Program To Help Payers Reduce Narcotic Abuse 8:00 a.m. Oct. 29, 2013 - PR Newswire
Express Scripts Reports Third Quarter 2013 Results 4:51 p.m. Oct. 24, 2013 - PR Newswire
Symbility Health Introduces Pharmacy Services Through Express Scripts Canada 8:03 a.m. Oct. 21, 2013 - Marketwire
Pre-Market Review: Express Scripts Holding Company, Cigna Corp., Health Net Inc., and Molina Healthcare Inc. 5:09 p.m. Oct. 18, 2013 - PR Newswire
Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December 9:03 a.m. Oct. 15, 2013 - PR Newswire
Eisai Announces Expansion of BELVIQ® (lorcaserin HCl) CIV Sales Specialists to Address Increased Payor Market 9:00 a.m. Oct. 15, 2013 - PR Newswire
Express Scripts Holding Company Announces Third Quarter 2013 Earnings Conference Call 1:42 p.m. Oct. 10, 2013 - GlobeNewswire
Express Scripts Presents 2014 Medicare Prescription Drug Plan Options, Including $0 Copay for Generics, 3,000 Covered Medications 8:00 a.m. Oct. 8, 2013 - PR Newswire
Health Studies, Partnerships, Philanthropic Activities, Recognitions, and Appointments - Research Report on Express Scripts, Cigna, Aetna, WellPoint, and Health Net 8:00 a.m. Sept. 24, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

McKay Brothers Enhances Fastest Routes for Market Data

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Shield HealthCare Expands Access for Astiva Members

Opening Up New Avenues for Health Care Here's a nugget from the healthcare sector that's worth chewing on. Shield HealthCare has just inked a deal with Astiva Health that opens the floodgates for eligible members in Southern California to access medical supplies through Shield's extensive network. It's a big move that aims to make health management a tad easier for folks...

Torchy's Tacos Reintroduces Nookies: Fan Favorite Returns

A Sweet Return to the Menu In the wild world of fast-casual dining, bringing back a beloved menu item is like striking gold. Torchy's Tacos is doing just that by reintroducing their legendary Nookies—fried chocolate chip cookie dough bites that have been a crowd favorite since 2008. After a two-year hiatus, these treats are back, complete with a cinnamon-sugar twist to...

CopperWood Senior Living Revives Historic Campus

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

ZYNLONTA's Japanese Push: ADC Therapeutics Gains Traction

ADC Therapeutics Eyes Japan with ZYNLONTA Bet These days, everyone seems to have their eyes on the Far East, and ADC Therapeutics is no exception. They're making a strategic leap by letting their budding blockbuster ZYNLONTA make waves in Japan. With the fresh file submitted for approval, it looks like they're hoping to capture market ground that could pay off big time...

LUNGevity's Every Breath Forward Drives Awareness and Action

A Bold New Campaign for Lung Cancer Awareness Amidst the hustle and bustle of daily life, a solemn campaign rises, taking aim at lung cancer's staggering toll on lives. LUNGevity Foundation is rolling out its initiative, Every Breath Forward?, this November, spotlighting unity and action during Lung Cancer Awareness Month. Forget the red carpets and flashy...

NIIT Expands with Bluewater: AI-Led Workforce Revolution

Big Moves in Talent Transformation There's a shakeup in the learning space, folks, and it's all about building a more AI-driven future. Today we're dissecting how NIIT Learning Systems Limited, a name that rings a bell in global managed learning, just snapped up Bluewater Learning. Not just a small fry acquisition, oh no—this one's got some meaty implications, tallying...

Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Eli Lilly Shifts Portfolio Focus, Boosts Outlook

Strong Quarter Signals Strategic Pivots Board a runaway train, folks, 'cause Eli Lilly (NYSE:LLY) is steaming ahead with third-quarter results that'll make any investor sit up and take notice. Revenue's up 39% to a hearty $24.4 billion, with Mounjaro and Zepbound doing some serious lifting. This ain't just small potatoes; it's full-on farm territory. Financial Peaks and...

Duolingo Lawsuit Looms Over Securities Allegations

Duolingo Lawsuit: A New Headache for Investors Seems like every time you blink, another tech darling is getting dragged to court, and now it's Duolingo's turn to face the music. They're locked in a class action lawsuit food-fight over violations of the Securities Exchange Act of 1934, specifically, §§10(b) and 20(a), and Rule 10b-5. The Core of Allegations Against...